Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
14JUN

Spinout deals fall 33% as seed dries up

2 min read
16:35UTC

University spinout equity deals fell 33% by count and 51% by value in 2025, extending a pipeline already skewed to sub-GBP500,000 rounds.

TechnologyDeveloping
Key takeaway

University spinout funding is drying up, thinning the pipeline of scale-ups Britain will have in 2027.

University spinout equity deals fell 33% by count and 51% by value in 2025, the sharpest contraction in the commercialisation pipeline this cycle, the British Business Bank tracker showed 1. It extends a figure already on the record: 36.7% of 2025 spinout rounds closed below GBP500,000.

Universities carve spinouts out of their research to commercialise it. Fewer seed-stage spinouts now means a shallower Series A pipeline in 2027, since the funding stages feed one another; capital that might have scaled university Science will chase other sectors instead.

The retail money that once seeded these companies has thinned. His Majesty's Revenue and Customs (HMRC) counted 33,220 investors using the Enterprise Investment Scheme (EIS), a tax relief for angels backing young firms, down 7% , before April's cut to Venture Capital Trust (VCT) relief compounded the fall. Private managers are rebuilding the tier by hand: Seedcamp closed a $320m fund , the Bank cornerstoned Longwall Ventures for sub-GBP2m cheques , and Lansdowne Partners anchored a university-IP fund . Each is selective, none is an open programme, so the recovery reaches some founders and not others.

Deep Analysis

In plain English

University spinouts are companies created to commercialise research done inside a university, such as a new drug or piece of hardware. In 2025 the number of spinout equity deals fell 33% and the total money raised fell 51%, with more than a third of all spinout rounds closing below £500,000, a very small amount for a company trying to build a product from a lab discovery. Much of the money that used to back these small, risky early rounds came from individual investors using tax reliefs called EIS and VCT. Government figures already showed 7% fewer people claiming that relief before ministers cut it further in April 2026, drying up one of the few funding taps spinouts could rely on.

Deep Analysis
Root Causes

Two separate mechanisms compound rather than one single cause. HMRC data already showed a 7% fall in EIS-claiming investors before this April's Venture Capital Trust relief cut took effect, meaning the retail angel base was thinning independently of the policy change.

The April 2026 VCT relief cut then removed a second, larger pool of retail capital that specifically fills reserve rounds below £2m, the exact size band where 36.7% of 2025 spinout rounds closed. Losing both pools within eighteen months hit the smallest deals hardest, because they have no alternative source of patient, tax-advantaged capital at that size.

What could happen next?
  • Consequence

    Fewer sub-£2m spinout rounds closing means fewer early-stage discoveries reach commercialisation at all, regardless of their eventual quality.

First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

British Business Bank· 4 Jul 2026
Read original
Causes and effects
This Event
Spinout deals fall 33% as seed dries up
A thinner spinout tier now feeds directly into a shallower Series A pipeline in 2027, independent of how much growth capital exists.
Different Perspectives
Fubon Financial
Fubon Financial
Fubon Financial joined Humanoid's Series A on 21 July as a minority financial investor alongside Schaeffler and Bosch, who also hold the customer and manufacturer roles. A pure-play investor from Taipei is pricing a London robot maker on terms two German industrial groups effectively set.
NATO Innovation Fund
NATO Innovation Fund
The Fund joined Greenjets' £30m Series A on 21 July alongside NSSIF, betting on ducted electric propulsion's civil market to fund a technology with an obvious defence application. It is backing a company that took twenty-one years to reach this stage, on the expectation that certification-cycle timelines reward patient capital over a quick return.
Prime Movers Lab
Prime Movers Lab
Prime Movers Lab led Humanoid's Series A on 21 July as the round's only pure financial investor, sharing the cap table with two co-investors who are also the anchor customer and the factory. That leaves the fund's usual arm's-length pricing role diluted by partners with a direct commercial stake in the valuation holding up.
Bosch and Schaeffler
Bosch and Schaeffler
Schaeffler signed what Humanoid calls the industry's largest publicly announced commercial agreement, while Bosch took equity and became contract manufacturer, filling capacity a shrinking combustion supply chain freed. Neither company has disclosed a unit count or an invoice, so their public commitment stops well short of Forbes' 100,000-unit projection.
UK founders raising seed through Series A
UK founders raising seed through Series A
A London robotics founder raised $152m this week against a signed industrial customer and a reserved factory, while a Cornwall founder more typically draws a £25,000 loan from a regional fund manager. Both call it British venture funding, but one route runs through Bosch's production line and the other through diligence built for businesses too small for any VC's attention.
EQT
EQT
EQT was reported on 3 July to be in advanced talks for a further CuspAI stake on behalf of the EU's Scaleup Europe Fund, but does not appear on the round CuspAI closed. Whether Europe's own sovereign vehicle secured a position, was outbid, or withdrew is unresolved.